Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Research & Development (2020 - 2025)

Historic Research & Development for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $9.0 million.

  • Cytek Biosciences' Research & Development fell 937.06% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year decrease of 818.29%. This contributed to the annual value of $39.4 million for FY2024, which is 1075.63% down from last year.
  • Cytek Biosciences' Research & Development amounted to $9.0 million in Q3 2025, which was down 937.06% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Research & Development ranged from a high of $12.1 million in Q2 2023 and a low of $5.1 million during Q1 2021
  • Over the past 5 years, Cytek Biosciences' median Research & Development value was $9.7 million (recorded in 2024), while the average stood at $9.0 million.
  • Per our database at Business Quant, Cytek Biosciences' Research & Development soared by 11241.43% in 2021 and then plummeted by 1759.23% in 2024.
  • Over the past 5 years, Cytek Biosciences' Research & Development (Quarter) stood at $7.1 million in 2021, then skyrocketed by 37.75% to $9.7 million in 2022, then rose by 11.51% to $10.9 million in 2023, then decreased by 10.54% to $9.7 million in 2024, then decreased by 7.89% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $8.8 million for Q2 2025, and $9.7 million during Q1 2025.